IFI-B · Prenylflavonoid Reduction Series

Specimen SS-F-BTR-843 // ZERO-BITTER · IFI-B

Prenylflavonoid · T1 Biolistic-A

Humulus lupulus

Hops

Tier IPrenylflavonoid Reduction Series

Target Trait

36%

% reduction

Isoxanthohumol/8-PN reduction

Technical Specifications

SKU

SS-F-BTR-843

Genomic Edits

3

GC Content

46.3%

Construct Length

2,502 bp

Promoter System

UBI-1 / 35S CaMV

Expression System

Biolistic particle bombardment

Host Strain

Gold particle 0.6 µm

Receptor Target

TAS2R38 (suppression)

IFI Score

36

Pathway Edits

  • OMT1 O-methyltransferase RNAi reduces xanthohumol-to-isoxanthohumol Cope rearrangement substrate availability
  • PrenylT prenyltransferase RNAi limits prenylation of naringenin chalcone at the C-8 position
  • CHS2 chalcone synthase isoform modification reduces xanthohumol precursor pool from phloroglucyl-CoA

Key Interventions

OMT1 methyltransferase RNAiPrenylT C-8 prenylase silencingCHS2 chalcone reduction

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
36
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier I Humulus lupulus lines for brewery applications targeting soft bitterness profiles, cosmetic and nutraceutical hop extracts requiring controlled 8-PN content, and non-alcoholic hop-flavored beverages where prenylflavonoid bitterness would detract from consumer palatability.

License

$299 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?